Advanced SearchSearch Tips
Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 Mutations in Breast Cancer Patients from North-East India
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 Mutations in Breast Cancer Patients from North-East India
Hansa, Jagadish; Kannan, Ravi; Ghosh, Sankar Kumar;
  PDF(new window)
Around 1.35 million people of worldwide suffer from breast cancer each year, whereas in India, 1 in every 17 women develops the disease. Mutations of the Breast Cancer 1 (BRCA1) gene account for the majority of breast/ovarian cancer families. The purpose of study was to provide a prevalence of BRCA1 germline mutations in the North-East Indian population. In relation to the personal and family history with the breast cancer, we found mutations in 6.25% and 12.5% respectively. Three mutations, 185DelAG, 1014DelGT and 3889DelAG, were observed in our North-East Indian patients in exons 2 and 11, resulting in truncation of the BRCA1 protein by forming stop codons individually at amino acid positions 39, 303 and 1265. Our results point to a necessity for an extensive mutation screening study of high risk breast cancer cases in our North-East Indian population, which will provide better decisive medical and surgical preventive options.
Breast cancer cases;BRCA1;mutations;North-East India;
 Cited by
BRCA1 Gene Exon 11 Mutations in Uighur and Han Women with Early-onset Sporadic Breast Cancer in the Northwest Region of China,;;;;;;;;;;

Asian Pacific Journal of Cancer Prevention, 2014. vol.15. 11, pp.4513-4518 crossref(new window)
BRCA1 and BRCA2 Common Mutations in Iranian Breast Cancer Patients: a Meta Analysis,;;;;;

Asian Pacific Journal of Cancer Prevention, 2015. vol.16. 3, pp.1219-1224 crossref(new window)
Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India,;;;;

Asian Pacific Journal of Cancer Prevention, 2015. vol.16. 17, pp.7929-7933 crossref(new window)
Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India, Asian Pacific Journal of Cancer Prevention, 2015, 16, 17, 7929  crossref(new windwow)
BRCA1 and BRCA2 Common Mutations in Iranian Breast Cancer Patients: a Meta Analysis, Asian Pacific Journal of Cancer Prevention, 2015, 16, 3, 1219  crossref(new windwow)
Screening for Del 185 AG and 4627C>A BRCA1 Mutations in Breast Cancer Patients from Lahore, Pakistan, Asian Pacific Journal of Cancer Prevention, 2016, 17, 4, 1725  crossref(new windwow)
A Pilot Study on Screening of BRCA1 Mutations (185delAG, 1294del40) in Nepalese Breast Cancer Patients, Asian Pacific Journal of Cancer Prevention, 2016, 17, 4, 1829  crossref(new windwow)
Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population, Tumor Biology, 2017, 39, 2, 101042831769430  crossref(new windwow)
Agarwal G, Ramakant P (2008). Breast cancer care in India: The current scenario and the challenges for the future. Breast Cancer, 3, 21-7.

Bar-Sade RB, Kruglikova A, Modan B, et al (1998). The 185DelAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Human Molecular Genetics, 7, 801-5. crossref(new window)

Brozek I, Cybulska C, Ratajska M, et al (2011). Prevalence of the most frequent BRCA1 mutations in polish population. J Appl Genetics, 52, 325-30. crossref(new window)

Claus E, Risch N, Thompson WD (1994). Autosomal dominant inheritance of early onset breast cancer. Cancer, 73, 643-51. crossref(new window)

Datta K, Biswas J (2009). Influence of dietary habits, physical activity and affluence factors on breast cancer in East India - A case-control Study. Asian Pac J Cancer Prev, 10, 219-22.

Farooq A, Naveed AK, Azeem Z, Ahmad T (2011). Breast and ovarian cancer risk due to prevalence of BRCA1 and BRCA2 variants in Pakistani population: A Pakistani database report. J Oncol, 2011, 1-8.

Ford D, Easton DF, Stratton M, et al (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 62, 676-89. crossref(new window)

Ghosh SK, Choudhury B, Hansa J, et al (2011). HPV testing for suspected cervical cancer patients from Southern Assam by fast-PCR. Asian Pac J Cancer Prev, 12, 749-51.

Greenberg RA (2008). Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network. Chromosoma, 117, 305-17. crossref(new window)

Hall JM, Lee MK, Newman B, et al (1990). Linkage of earlyonset familial breast cancer to chromosome17q21. Sci, 250, 1684-9. crossref(new window)

Hedau S, Jain N, Syed A, Husain, Das BC (2004). Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res and Treatment, 88, 177-86. crossref(new window)

12. Breast Cancer informationcore (NHGRI)

Kumar BV, Lakhotia S, Ankathil R, et al (2002). Germline BRCA1 mutation analysis in Indian Breast/Ovarian cancer families. Cancer Biol Ther, 1, 18-21. crossref(new window)

Lakhotia, Somasundaram (2010). Conformation Sensitive Gel Electrophoresis for detecting BRCA1 mutations. Methods in Molecular Biol, 223, 403-14.

Liang SX, Pearl M, Liang S, et al (2011). Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger. Int J Cancer, 128, 763-70. crossref(new window)

Liede A, Malik IA, Aziz Z, et al (2009). Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan. Am J Hum Genet, 71, 595-606.

Mangtani P, Maringe C, Rachet B, Coleman MP, Silva IDS (2010). Cancer mortality in ethnic South Asian migrants in England and Wales (1993-2003): patterns in the overall population and in first and subsequent generations. Br J Cancer, 102, 1438-43. crossref(new window)

Mathew A, Pandey M, Rajan B (2004). Do younger woman with non-metastatic and non-inflammatory breast carcinoma have poor prognosis? World J Surg Oncol, 2, 2. crossref(new window)

Metcalfe K, Lubinski J, Lynch HT, et al (2010). Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. JNCI, 102, 1874-78. crossref(new window)

Miki Y, Swensen J, Shattuck-Eidens D, et al (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71. crossref(new window)

Narod SA (2011). Screening of women at high risk for breast cancer. Prev Med, 52, 127-30.

Roy R, Chun J, Powell SN (2012). BRCA1 & BRCA2: different roles in a common pathway of genome protection. Nature Reviews Cancer, 12, 68-78.

Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010). Profile of breast cancer patients at a tertiary care hospital in North India. Indian J Cancer, 17, 16-22.

Saxena S, Kaushal M, Sharma J, Zomawia E Kapur S (2010). Genomic alteraions in breast cancer patients from Northeast India using 10K SNP arrays. Genome Biol, 11, 34.

Saxena S, Chakraborty A, Kaushal M, et al (2006). Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet, 7, 75. crossref(new window)

Saxena S, Rekhi B, Bansal A, et al (2005). Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study.World J Surg Oncol, 3, 1-8. crossref(new window)

Thirthagiri E, Lee SY, Kang P, et al (2008). Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res, 10, R59. crossref(new window)

Valarmathi MT, Sawhney M, Suryanarayana SV, et al (2004). Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Hum Mutat, 23, 205.

Wong NS, Anderson BO, Khoo KS, et al (2009). Management of HER2-positive breast cancer in Asia: consensus statement from Asian Oncology Summit 2009. Lancet Oncol, 10, 1077-85. crossref(new window)

Wooster R, Weber BL (2010). Breast and ovarian cancer. N Engl J Med 2003, 348, 2339-47.

Zhang H, Somasundaram K, Peng Y (????). BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene, 16, 1713-1721.